Malaria drug shows promise for hard-to-treat multiple sclerosis
Feb 16, 2022
1 minute
he antimalarial drug hydroxychloroquine could be a promising treatment candidate for slowing the progression of a rare form of multiple sclerosis (MS). In a small trial, patients who received the drug were less likely to significantly worsen over
You’re reading a preview, subscribe to read more.
Start your free 30 days